Cargando…

Evaluating new treatments for advanced cancer

Detalles Bibliográficos
Autor principal:	Botwood, Nicholas
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2001
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363917/ https://www.ncbi.nlm.nih.gov/pubmed/11437417 http://dx.doi.org/10.1054/bjoc.2001.1887

Ejemplares similares

Evaluating new treatments for advanced cancer – reply
por: Ferguson, Jamie
Publicado: (2001)

Comment on: hyperthermic intraperitoneal chemotherapy as consolidation treatment of advanced stage ovarian cancer
por: Venkatappa, Shalini, et al.
Publicado: (2022)

Pembrolizumab: A reliable second‐line treatment option for advanced esophageal cancer
por: Zheng, Li, et al.
Publicado: (2022)

Is gemcitabine (GEM)-based combination therapy good for the treatment of advanced pancreatic cancer?
por: Hao, Fulong, et al.
Publicado: (2023)

A new risk-assessment tool for venous thromboembolism in advanced lung cancer: a prospective, observational study
por: Tsubata, Yukari, et al.
Publicado: (2022)

Feasibility and safety of EUS-guided radiofrequency ablation in treatment of locally advanced, unresectable pancreatic cancer
por: Jiang, Jieling, et al.
Publicado: (2021)

RE: Cost-utility of talazoparib monotherapy treatment for locally advanced or metastatic breast cancer in Spain
por: Zou, Denise, et al.
Publicado: (2021)

One case of comprehensive treatment for advanced liver cancer followed up over three years
por: Liang, Hai-Yan, et al.
Publicado: (2022)

Lung autotransplantation for the treatment of locally advanced tumors
por: de Brito, João Marcelo Lopes Toscano, et al.
Publicado: (2021)

Very high-risk prostate cancer: multimodality treatment will be the new frontier
por: Campobasso, Davide, et al.
Publicado: (2017)

New Avenues Towards Prevention and Treatment of Mucositis Induced by Cancer Therapies
por: Zambrano, Angela R., et al.
Publicado: (2021)

Evaluating the Usability of Electronic Patient-Reported Outcome Apps: Comment on a Symptom Management Platform for Outpatients With Advanced Cancer
por: Haniuda, Yu, et al.
Publicado: (2023)

DCvax: A promising advancement in oncology for the treatment of glioblastoma
por: Fareed, Areeba, et al.
Publicado: (2023)

Combination chemotherapy for advanced colorectal cancer
por: Mason, M, et al.
Publicado: (2003)

The definition of locally advanced pancreatic cancer
por: Zanini, N, et al.
Publicado: (2010)

Characterizing tumor shrinkage as a measure of clinical benefit for immune checkpoint inhibitors
por: Kelleher, Thomas, et al.
Publicado: (2021)

Advancing our understanding of the neurobiology of anorexia nervosa: translation into treatment
por: Bang, Lasse, et al.
Publicado: (2017)

Reply to: The definition of locally advanced pancreatic cancer
por: Boeck, S, et al.
Publicado: (2010)

Pure erythroid leukemia in advanced breast cancer
por: Niscola, Pasquale, et al.
Publicado: (2014)

Sonidegib with and Without Adjunctive Treatment for Locally Advanced Basal Cell Carcinomas
por: Villani, Alessia, et al.
Publicado: (2022)

Evaluation of a new laryngoscope according to preparation time
por: Imashuku, Yasuhiko, et al.
Publicado: (2018)

Aromatase inhibitors in advanced breast cancer: there are efficacy differences
por: Bhatnagar, A S
Publicado: (2005)

Pharmacoeconomic evaluations in the treatment of actinic keratoses
por: Tolley, Keith, et al.
Publicado: (2017)

Paracoccidioidomycosis: evaluation of treatment and patient profile
por: Fiol, Fernando Sá Del, et al.
Publicado: (2013)

Covid-19 pandemic: A new contributing factor to diagnostic and treatment delay in oral cancer patients
por: Varela-Centelles, Pablo, et al.
Publicado: (2021)

Careful consideration should be paid in the new imaging modality evaluation
por: Sekine, Tetsuro, et al.
Publicado: (2021)

Clinical impact of extensive molecular profiling in advanced cancer patients
por: Cousin, Sophie, et al.
Publicado: (2017)

Use of opioids as one of the causes of fever in patients with advanced cancer
por: Graczyk, Michał, et al.
Publicado: (2017)

Caring for Patients with Advanced Stage Cancer at the Time of COVID‐19
por: Brunello, Antonella, et al.
Publicado: (2020)

Preclinical Evaluation of Safety of Fucoidan Extracts From Undaria pinnatifida and Fucus vesiculosus for Use in Cancer Treatment
por: Bovet, Luc, et al.
Publicado: (2019)

New Clinical Implications of Opiate Maintenance Treatments
por: Haro, Gonzalo
Publicado: (2012)

The New Advance at the International Congress of School Hygiene
por: Brunton, Lauder, et al.
Publicado: (1907)

Long-term treatment with pacritinib on a compassionate use basis in patients with advanced myelofibrosis
por: Harrison, Claire, et al.
Publicado: (2023)

Treatment options for patients with HR+/HER2− advanced breast cancer during the COVID-19 pandemic: dose reduction of ribociclib does not diminish efficacy
por: O’Shaughnessy, Joyce
Publicado: (2020)

A phase II study on Mefatinib as first‐line treatment of patients with advanced non‐small‐cell lung cancer harboring uncommon EGFR mutations
por: Wang, Pingli, et al.
Publicado: (2023)

Effectiveness of Ankaferd BloodStopper in Prophylaxis and Treatment of Oral Mucositis in Childhood Cancers Evaluated with Plasma Citrulline Levels
por: Patıroğlu, Türkan, et al.
Publicado: (2018)

Advanced forecasting of SARS‐CoV‐2‐related deaths in Italy, Germany, Spain, and New York State
por: Sotgiu, Giovanni, et al.
Publicado: (2020)

Does an old dog need new tricks? Advancement of limb salvage in treating chronic limb threatening ischemia
por: O'Banion, Leigh Ann
Publicado: (2023)

Extended pelvic side wall excision for locally advanced rectal cancers
por: Shaikh, Irshad A, et al.
Publicado: (2017)

A New Treatment Approach for Acute Paraquat Poisoning
por: Dorooshi, Gholamali, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_mq1cbjbru5m1okccuarkipo38l